1220.7.1011 Boehringer Ingelheim Investigational Site

Calgary, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C, Chronic

Studies at this site

• Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3) — Completed